Criterium Inc, Global CRO and The Oncology Consortia of Criterium are currently collaborating with our investigators and leading pharmaceutical partners on a number of exciting trials.
The following Myeloma Consortium clinical research trials are currently open and/or enrolling patients at the member and affiliate sites:
Relapsed/Refractory Multiple Myeloma / Ph I
IMGN901 in Combination with Lenalidomide and Dexamethasone in Patients with CD56-positive Relapsed or Relapsed/Refractory Multiple Myeloma
Clinical Trials.gov Trial ID NCT00991562
Relapsed/Refractory Multiple Myeloma / Phase I/II
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical Trials.gov Trial ID NCT01464034
Newly Diagnosed Multiple Myeloma / Ph Ib
A Safety Study of Carfilzomib With Cyclophosphamide and Dexamethasone Prior to Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma.
Clinical Trials.gov Trial ID NCT01660750
Systemic Light Chain Amyloidosis / Ph I
A Safety Study of Carfilzomib in Patients with Previously-Treated Systemic Light Chain Amyloidosis.
Clinical Trials.gov Trial ID NCT01789242
The following GI Cancer Consortium clinical research trials are currently open and/or enrolling patients at the member and affiliate sites:
Pancreatic Cancer / Ph III
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer (ONTRAC)
Clinical Trials.gov Trial ID NCT01360853
The following Criterium Inc GLOBAL CRO clinical research trials are currently open and /or enrolling patients:
Multiple Myeloma / Ph I
Safety and Tolerability Study of SNS01-T in Relapsed or Refractory Multiple Myeloma, Mantle Cell Lymphoma, or Diffuse Large B Cell Lymphoma
Clinical Trials.gov Trial ID NCT01435720
Infectious Disease / Ph II
Evaluation of Safety, PK and Immunomodulatory Effects of AB103 in Necrotizing Soft Tissue Infections Patients
Clinical Trials.gov Trial ID NCT01417780
Burn Wound Study / Ph IV
Study of Low Adherent Dressing Versus the Standard of Care for the Management of Skin Grafts Over Thermal Burns
Clinical Trials.gov Trial ID NCT01654094
Hypogonadal Men (Testosterone) / Ph IV
Please check back soon for updates.